As the only multimodality imaging system to combine both intravascular ultrasound (IVUS) and near-infrared spectroscopy (NIRS), the TVC Imaging System provides clear and relevant information about vessel structure, in real time. The TVC Imaging System is the only system available in both the U.S. and Europe for the detection of LCPs. NIRS measurements have been made in over 9,000 patients in over 100 hospitals worldwide.
About Infraredx, Inc.
Ad Statistics
Times Displayed: 22362
Times Visited: 450 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
Infraredx, Inc. was founded in 1998 by James Muller, MD on the premise that vulnerable plaque plays a key role in the cause of heart attacks. Infraredx is a privately-funded medical device company dedicated to help provide practitioners with specific information to enhance timely clinical decision-making in the treatment of coronary artery disease. The company has committed over $40 million to clinical research aimed at identifying vulnerable plaque and its role in coronary artery disease, improving the safety and efficacy of coronary stenting, and ultimately serving as part of a strategy to prevent initial coronary events.
Through its TVC Imaging System™, Infraredx is changing the way coronary artery disease is diagnosed and treated. The TVC Imaging System is the only intravascular imaging system that enables true vessel characterization through simultaneous structural and compositional imaging data obtained in a single pullback. Infraredx is headquartered in Burlington, Mass. For more information, visit www.infraredx.com.
Contacts:
Infraredx
Grant Frazier
Vice President of Marketing
Infraredx, Inc.
781-345-9632
gfrazier@infraredx.com
Susan Heins (media)
Pure Communications, Inc.
864-286-9597
sjheins@purecommunicationsinc.com
Back to HCB News
